CDRH Officials Reveal Top Challenges To Executing User Fee Updates
This article was originally published in The Gray Sheet
Executive Summary
Hiring and retaining the staff, adjusting the internal culture at CDRH and rebuilding relationships with industry and other public stakeholders are among FDA’s top challenges in meeting the demands of the new device user fee program, according to CDRH Director Jeffrey Shuren.